CPHD

CEPHEID News Headlines

$38.77
*  
1.13
3%
Get CPHD Alerts
*Delayed - data as of Aug. 1, 2014  -  Find a broker to begin trading CPHD now
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Thoratec Upgraded to Neutral - Analyst Blog
4/12/2013 2:07:38 PM - Zacks.com

FDA Approves TFX's ISO-Gard Mask - Analyst Blog
4/12/2013 9:08:31 AM - Zacks.com

Product Recall Plagues Integra - Analyst Blog
4/11/2013 3:10:00 PM - Zacks.com

BioScrip Raised to Outperform - Analyst Blog
4/10/2013 5:07:25 PM - Zacks.com

Merge Enhances eClinical OS Platform - Analyst Blog
4/10/2013 3:08:33 PM - Zacks.com

Safeway's Blackhawk Settles IPO Price - Analyst Blog
4/9/2013 3:11:13 PM - Zacks.com

Hologic Reiterated at Neutral - Analyst Blog
4/8/2013 3:10:30 PM - Zacks.com

CYBX Resumes Reimbursement Efforts - Analyst Blog
4/8/2013 3:07:35 PM - Zacks.com

Milestone for Accuray TomoTherapy - Analyst Blog
4/5/2013 3:09:37 PM - Zacks.com

Still Neutral on Merge Healthcare - Analyst Blog
4/5/2013 2:07:18 PM - Zacks.com

Mindray to Exhibit at CMEF - Analyst Blog
4/4/2013 2:06:02 PM - Zacks.com

Abiomed Begins Impella RP Trial - Analyst Blog
4/3/2013 9:22:38 AM - Zacks.com

ResMed Protects Patent Landscape - Analyst Blog
4/2/2013 2:18:25 PM - Zacks.com

Zacks Rank #1 Addition for Tuesday - Tale of the Tape
4/2/2013 9:10:16 AM - Zacks.com

Collaborative Research for Cepheid - Analyst Blog
2/21/2013 3:20:01 PM - Zacks.com

Still Neutral on Cepheid - Analyst Blog
2/12/2013 3:30:01 PM - Zacks.com

Abaxis Surpasses Estimates in 3Q - Analyst Blog
2/1/2013 3:40:01 PM - Zacks.com

All-Front Easy Beat for Covance - Analyst Blog
1/28/2013 9:40:01 AM - Zacks.com

Cepheid Turns to Profit in 4Q - Analyst Blog
1/25/2013 11:50:01 AM - Zacks.com

FDA Categorizes Cepheid's New Test - Analyst Blog
1/16/2013 3:50:01 PM - Zacks.com

Cepheid Unveils Prelim 4Q Results - Analyst Blog
1/10/2013 3:40:01 PM - Zacks.com

Medtech News Over The Christmas Period
1/2/2013 11:57:00 AM - Seeking Alpha

FDA Nod for Cepheid's Latest Test - Analyst Blog
12/28/2012 12:40:01 PM - Zacks.com

Time For Hologic To Translate Technology Into Results (HOLX, GE, CPHD, BDX)
11/14/2012 10:39:00 AM - Investopedia

Mixed 2Q for Abaxis - Analyst Blog
10/26/2012 11:29:40 AM - Zacks.com